News

News

August 19, 2020

BioStock article: Follicum reaches milestone in hair study

BioStock published an article on 19 August 2020 about Follicum, which can be read in full below. Yesterday, Follicum announced that they have recruited over 50 per cent of the intended patient group for their ongoing phase IIa trial with the topical formulation of the hair growth stimulating candidate FOL-005. Thus, the study is well on […]

June 25, 2020

BioStock article: New patent notice rounds off an eventful six months for Follicum

BioStock published an article on 25 June 2020 about Follicum, which can be read in full below. During the first half of 2020, Follicum has started, paused and resumed a phase II study with its primary candidate FOL-005. An international patent application has been filed regarding its newly developed topical formulation as a carrier of […]

June 17, 2020

BioStock article: Follicum represents R&D at MVA’s diabetes webinar

BioStock published an article on 17 June 2020 about Follicum, which can be read in full below. Tomorrow, world-leading diabetes experts and front runners of regional R&D in type 1 diabetes will gather at a free Medicon Valley Alliance webinar. Lund-based Follicum will be among the participants, and BioStock has talked to CEO Jan Alenfall […]

May 12, 2020

BioStock article: Follicum applies for extended patent for its topical formulation

BioStock published an article on 12 May 2020 about Follicum, which can be read in full below. The peptide specialist company Follicum has filed an international patent application for its topical cream formulation. The application is both relevant for the company’s furthest-advanced candidate, FOL-005, which is currently undergoing a clinical phase IIa study in hair […]

April 27, 2020

BioStock article: The psychosocial consequences of hair loss

BioStock published an article on 27 April 2020 about hair loss and Follicum, which can be read in full below. Hair loss is a benign condition with limited physical effects, but the psychosocial aspects are more severe. Hair is a key part of our self-image and self-expression, aspects that can be ruthlessly squashed by hair […]

March 25, 2020

BioStock article: Follicum comments on patent notice for diabetes candidate

BioStock published an article on 25 March 2020 about Follicum, which can be read in full below. Follicum’s diabetes project took a big leap forward last Friday with a preliminary patent approval from the European Patent Office regarding the company’s diabetes peptides. BioStock contacted CEO Jan Alenfall to find out more about the project, the patent […]

March 9, 2020

BioStock article: Female alopecia – new solutions on the horizon

BioStock published an article on 9 March 2020 about female alopecia, which can be read in full below. Hair loss is common, and, while it does not necessarily come with any serious health complications, the stigma can be debilitating. This is especially true in women, who are often neglected in the discussions around alopecia. On […]

February 4, 2020

BioStock article: Follicum’s CEO comments on the study approval and Vinnova grant

BioStock published an article on 4 February 2020 about Follicum, which can be read in full below. FOL-005, Follicum’s hair growth candidate, has received approval from German authorities to initiate a phase IIa study. Patient recruitment will commence shortly, and initial results are expected before the end of the year. The company’s aim is to then […]

January 20, 2020

BioStock-article: The rise of therapeutic peptides: Follicum at the forefront

BioStock published an article on 20 January 2020 about Follicum, which can be read in full below. Pharmaceutical drugs are often subdivided into two fractions: small molecules and large molecules (or biologics). However, a third category called peptides falls right in-between, thus generating an overlap of benefits from the other classes of molecules. Follicum’s two projects, […]

December 18, 2019

BioStock article: 2019 in review: Follicum ready for phase II with hair loss candidate

BioStock published an article on 18 December 2019 about Follicum, which can be read in full below. Both of Follicum’s projects, FOL-005 and the diabetes peptides, have reached important milestones this year. A topical formulation of the company’s hair loss treatment has successfully completed toxicology and safety profile clinical studies, and Follicum is all set […]